KPV— 10 mg

KPV — 10 mg

KPV is a synthetic tripeptide derived from the C-terminal sequence of alpha-melanocyte–stimulating hormone (α-MSH), widely studied in research settings for its selective interaction with inflammatory and immune-related signaling pathways. Researchers examine it for how it influences cytokine modulation, epithelial barrier signaling, and downstream cellular response markers without broadly activating endocrine or melanocortin hormone pathways.

Key Research Observations on KPV

Selective inflammatory pathway modulation
Research literature describes KPV as a peptide investigated for its role in regulating inflammatory cytokine signaling, particularly in localized and tissue-specific immune response models.

Focus on epithelial and barrier integrity signaling
Studies explore how KPV may influence pathways related to epithelial tissue stability and barrier function, making it a subject of interest in gastrointestinal and mucosal research contexts.

Minimal activation of melanocortin endocrine pathways
Scientific investigations note that KPV preserves anti-inflammatory signaling characteristics of α-MSH–derived sequences without triggering broader melanocortin or endocrine hormone effects.

Interest in immune balance and stress-response research
Academic and preclinical research examines KPV for its downstream effects on immune regulation markers, cellular stress responses, and tissue-level signaling dynamics under controlled research conditions.